Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro does not come in a 3.75mg strength. The licensed UK doses are 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg — no half-steps exist in the manufactured pen range. If you have seen 3.75mg mentioned online, it almost certainly refers to a specific technique for drawing a partial dose from a 5mg pen, not an officially supplied strength. That distinction matters, because the way Mounjaro is prescribed, dispensed and dosed in the UK is tightly governed as a prescription-only medicine. Any decision about whether you should take something other than the dose your prescriber has written for you is exactly the kind of question to raise with them before you act on it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you're mid-treatment, you've finished your 2.5mg starter month, and someone in an online group mentions they take exactly half of a 5mg pen to land at 3.75mg. It sounds sensible on paper. If 2.5mg is the start and 5mg is the next step, surely halfway is a gentler bridge?
The problem is that Mounjaro's KwikPen is pre-filled and pre-set. Each pen holds four doses at a fixed amount, you cannot adjust the dial or draw a precise fraction. To get approximately 3.75mg someone would need to use a separate syringe to withdraw roughly half the volume from the pen's cartridge, which voids the sterile delivery system and introduces real risks: contamination, air bubbles, inaccurate dosing. The NHS tirzepatide guidance covers the licensed delivery method clearly, and drawing from the cartridge is not part of it.
If you want to understand exactly how many ml 3.75mg would represent in a Mounjaro pen, that page gives the volume context. But volume knowledge alone does not make the technique safe or prescribed. The question is not whether the maths works; it's whether your prescriber has assessed you and explicitly recommended that approach. Without that conversation first, acting on forum advice about off-label partial dosing is a genuine safety gap.
Worth spending thirty seconds on: open the Patient Information Leaflet that came with your pen. The injection instructions section will confirm this delivery method and the fixed dose per injection. If your leaflet says something different from what a forum post suggests, the leaflet wins.
The titration schedule for Mounjaro exists for a specific reason. The 5mg dose follows the 2.5mg starter period not because someone picked a round number, but because the four-week starter phase gives your digestive system time to adapt to tirzepatide's effects on gastric emptying. Most of the nausea and GI discomfort people experience is most pronounced in that adjustment window. By the time a prescriber considers moving you to 5mg, they are making a clinical judgement that your tolerance has stabilised enough for the full next step.
An improvised 3.75mg middle ground bypasses that assessment entirely. You might feel you need it (and that feeling is valid) but a prescriber might instead suggest staying at 2.5mg a little longer, or might identify another reason your symptoms are persisting that has nothing to do with the dose size. Titration timing is one of the things a prescriber reviews before every repeat order at nume; it is not a calculation you should have to make alone at home.
If you are trying to move from a 2.5mg pen to a 5mg one and want to understand the transition, the guidance on taking an intermediate dose from a 5mg pen covers the context that prompts this question. Read it alongside whatever your own prescriber advises, not instead of it.
In the UK, Mounjaro is licensed for adults with a BMI of 30 or above, or 27 or above if at least one weight-related condition is present, things like type 2 diabetes, high blood pressure or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. These are licence conditions; the 3.75mg question sits outside them entirely, because 3.75mg is not a licensed dose.
NICE's appraisal of tirzepatide (TA1026) recommends the medicine for eligible adults with a BMI of 35 or above plus at least one weight-related comorbidity for NHS use, though private routes follow the broader SmPC eligibility. Either way, the dose a person takes is part of the clinical assessment, not a consumer choice to be optimised independently.
If you are already on a prescribed dose and wondering whether splitting the pen to slow your titration is a good idea, that is a legitimate concern to raise, but raise it with your prescriber. Dose timing, tolerance and whether to pause a titration step are decisions that benefit from someone who knows your medical history. If you are not yet on Mounjaro and trying to work out whether this medicine and its titration schedule is right for you, that conversation starts with a free consultation with our clinical team rather than with a calculation based on a forum post.
For a broader look at how Mounjaro fits into the private weight-loss landscape, including cost context worth reading before you commit, the Mounjaro price comparison page covers the market honestly.
The most common reason someone searches for an intermediate dose like 3.75mg is that their current dose feels either too strong or not strong enough. Both are real experiences worth addressing, neither is best addressed by improvised pen manipulation.
Too much nausea at 2.5mg? A prescriber can advise on whether to extend the starter period, adjust injection timing, or consider whether something in your diet around injection day is making things worse. Feeling no effect at 2.5mg after the full four weeks? That is exactly the kind of update that triggers a legitimate titration step. If you're wondering whether taking two 2.5mg doses could be an alternative, the short answer is no, that page explains why doubling doses is not the same as moving to the next licensed strength.
Similarly, if you've arrived at this question because you have a 2.5mg pen and are trying to draw more from it, the volume maths do not support what you might hope. The pen contains 0.5ml at 2.5mg; there is no hidden extra dose to access.
The clearest path is always the same: tell your prescriber what you are experiencing, ask about your titration timeline and trust that a real clinical review (not a workaround) is how this medicine works best. Our prescribers at nume review every repeat order before it is approved, precisely so that questions like this get answered properly rather than left to guesswork. If you have a question between orders, our aftercare team is reachable seven days a week through contact.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.